A citation-based method for searching scientific literature

Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters, Sangeeta Sawhney, Paul Strumph. Diabetes Care 2018
Times Cited: 88







List of co-cited articles
994 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
5
20

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.
Muhammad A Abdul-Ghani, Luke Norton, Ralph A Defronzo. Endocr Rev 2011
280
1








Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.
Prashanth Rawla, Anantha R Vellipuram, Sathyajit S Bandaru, Jeffrey Pradeep Raj. Endocrinol Diabetes Metab Case Rep 2017
29
3



Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy.
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
12
8

Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.
Richard A Koch, Richard F Clark. Am J Ther 2018
1
100


Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
7
14

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
7
14

Euglisemic diabetic ketoacidotic coma caused by dapagliflozin.
Zeynep Karakaya, Fatih Esad Topal, Firdes Topal, Umut Payza, Pınar Yeşim Akyol. Am J Emerg Med 2018
6
16

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.
George L Bakris, Vivian A Fonseca, Kumar Sharma, Ernest M Wright. Kidney Int 2009
210
1

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin.
Junichiro Adachi, Yuusuke Inaba, Chisato Maki. Intern Med 2017
14
7

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
22
4


Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
5
20

Euglycemic Diabetic Ketoacidosis Due to Gastroparesis, A Local Experience.
Ronillo Legaspi, Philipp Narciso. J Ark Med Soc 2015
9
11

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
8
12

The effect of SGLT2 inhibitors on cardiovascular events and renal function.
Konstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, Asterios Karagiannis, Vasilios G Athyros. Expert Rev Clin Pharmacol 2017
9
11



Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
4
25

Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis.
Zhehao Dai, Yosuke Nishihata, Naoto Kawamatsu, Ikki Komatsu, Atsushi Mizuno, Masato Shimizu, Nozomi Toya, Shinichi Ishimatsu, Nobuyuki Komiyama. J Cardiol Cases 2016
4
25

Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.
Shreya Pujara, Adriana Ioachimescu. J Investig Med High Impact Case Rep 2017
20
5



Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.
I Sadaf Farooqi, Giuseppe Matarese, Graham M Lord, Julia M Keogh, Elizabeth Lawrence, Chizo Agwu, Veronica Sanna, Susan A Jebb, Francesco Perna, Silvia Fontana,[...]. J Clin Invest 2002
924
1

Molecular pharmacology of the secretin receptor.
Maoqing Dong, Laurence J Miller. Recept Channels 2002
39
2

The catabolic action of insulin in the brain is mediated by melanocortins.
Stephen C Benoit, Ellen L Air, Lique M Coolen, Richelle Strauss, Alana Jackman, Deborah J Clegg, Randy J Seeley, Stephen C Woods. J Neurosci 2002
268
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.